Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
REVENUES:
Revenues	$ (163,971)	$ 20,610	$ (452,531)	$ 117,989
OPERATING EXPENSES:
Cost of products sold	29,400	0	54,600	0
Research and development	4,011,418	3,257,624	6,935,269	6,385,113
Selling, general and administrative	5,044,913	2,404,093	7,376,519	4,236,535
Gain on license termination agreement	0	0	(1,623,795)	0
Total operating expenses	9,085,731	5,661,717	12,742,593	10,621,648
Loss from operations	(9,249,702)	(5,641,107)	(13,195,124)	(10,503,659)
OTHER (EXPENSE) INCOME:
Investment income	4,800	399,982	16,935	770,636
Foreign currency loss	(745,002)	0	(745,002)	0
Interest expense	(1,871)	(2,502)	(9,360)	(11,553)
Total other (expense) income, net	(742,073)	397,480	(737,427)	759,083
Net loss	$ (9,991,775)	$ (5,243,627)	$ (13,932,551)	$ (9,744,576)
Basic and diluted net loss per common share	$ (0.04)	$ (0.02)	$ (0.06)	$ (0.04)
Weighted average number of common shares outstanding used in computing basic and diluted net loss per common share	236,405,065	234,923,592	236,375,463	234,018,417
Product Revenue
REVENUES:
Revenues	$ (163,971)	$ 0	$ (452,531)	$ 0
License and Contract
REVENUES:
Revenues	$ 0	$ 20,610	$ 0	$ 117,989